caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1578721858

Thomas KaleyM.D,

NeurologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Thomas Kaley's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 11 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Jamie Tisnado
Diagnostic Radiology · New York, NY
3373
Robert Young
Diagnostic Radiology · New York, NY
2467
Dipti Gupta
Cardiology · New York, NY
2244
Alan Carver
Neurology · New York, NY
2196
Xi Chen
Neurology · New York, NY
1737
Howard Weinstein
Cardiology · New York, NY
1627
Alison Gilgan
Nurse Practitioner · New York, NY
1468
Jennifer Liu
Cardiology · Manhasset, NY
1419
Eli Diamond
Neurology · New York, NY
1234
Eileen Mcaleer
Cardiology · New York, NY
1225
Peter Maslak
Hematology · Buffalo, NY
1123
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
229
Unique beneficiaries
—
Total services
310
Distinct HCPCS
4
Medicare payment
$37K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,430 Neurology providers in NY — below median (cohort median 560).
PRESCRIBING · PART D · 2024
Total Rx claims
53
Beneficiaries
—
Total drug cost
$457
Distinct drugs
4
Brand share
20.8%
Top prescribed drugs
Dexamethasone15 claims
Levetiracetam15 claims
Gabapentin12 claims
Sulfamethoxazole/Trimethoprim11 claims
QUALITY · MIPS · 2024
Final MIPS score
80.4
Quality
74.7
Cost
69.1
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.23%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$6K
Payment records
3
By payment type
Consulting Fee$5K
Travel and Lodging$538